PRC 2 is dispensable for HOTAIR ‐mediated transcriptional repression-Reference-Cited by-同舟云学术

PRC 2 is dispensable for HOTAIR ‐mediated transcriptional repression

Published:2017-02-06 Issue:8 Volume:36 Page:981-994
ISSN:0261-4189
Container-title:The EMBO Journal
language:en
Short-container-title:EMBO J

Author:

Portoso Manuela¹²,Ragazzini Roberta¹²,Brenčič Živa¹²,Moiani Arianna¹²,Michaud Audrey¹²,Vassilev Ivaylo¹²,Wassef Michel¹²,Servant Nicolas¹³,Sargueil Bruno⁴,Margueron Raphaël¹²^ORCID

Affiliation:

1. Institut Curie PSL Research University Paris France

2. INSERM U934 CNRS UMR3215 Paris France

3. INSERM U900 Mines ParisTech Paris France

4. CNRS UMR 8015 Université Paris Descartes Paris France

Funder

Institut National Du Cancer

Agence Nationale de la Recherche

Cancéropôle Île-de-France

Seventh Framework Programme

Publisher

EMBO

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,Molecular Biology,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/embj.201695335

Reference50 articles.

1. Modeling of epigenome dynamics identifies transcription factors that mediate Polycomb targeting

2. The interaction of PRC2 with RNA or chromatin is mutually antagonistic

3. Noncoding RNA and Polycomb recruitment

4. Evf2 lncRNA/BRG1/DLX1 interactions reveal RNA-dependent chromatin remodeling inhibition

5. The Noncoding RNA Revolution—Trashing Old Rules to Forge New Ones

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ST8SIA6-AS1, a novel lncRNA star in liver cancer;Frontiers in Cell and Developmental Biology;2024-08-15

2. Regulatory RNAs: role as scaffolds assembling protein complexes and their epigenetic deregulation;Exploration of Targeted Anti-tumor Therapy;2024-07-22

3. Molecular insights into regulatory RNAs in the cellular machinery;Experimental & Molecular Medicine;2024-06-14

4. The role of HOTAIR in the modulation of resistance to anticancer therapy;Frontiers in Molecular Biosciences;2024-06-03

5. Polycomb repressive complex 2 and its core component EZH2: potential targeted therapeutic strategies for head and neck squamous cell carcinoma;Clinical Epigenetics;2024-04-10